Only the L-isomer of carnitine is biologically active
But patients, advocacy groups and pharmaceutical companies have long argued the path leading up to the PBS listing is overly complex, involves excessive red tape and takes too long, with a median time of 22 months for a new medicine to land on the scheme once it is approved by the regulator
TRIUMPH-4 (28.7% weight loss, knee OA population, December 2025), TRIUMPH-1 (28.3%, general obesity, May 2026), TRANSCEND-T2D-1 (-2.0% HbA1c, 16.8% weight loss, June 2026), TRIUMPH-2 (20.8% weight loss, obesity + diabetes, July 23, 2026), and TRIUMPH-3 (22.6% weight loss, obesity + cardiovascular disease, July 23, 2026) have all reported positive results
This high regenerative and healing ability was found to function not only for plethora of soft tissues, muscles and ligaments, but also for inner organs, skin, nervous system and in the context of conditions such as ulcers, Crohn's disease or leaky gut problems
Federal health authorities continue to flag significant clinical concerns, including immunogenicity risks and the theoretical potential to stimulate oncogenic (cancer) pathways
Glutathiones benefits for liver detoxification, immune support, and oxidative stress management occur at the intracellular level, not in the intestinal tract